Innovative smart pill bottles significantly enhance adherence to oral adjuvant endocrine therapy in early-stage breast cancer ...
Please provide your email address to receive an email when new articles are posted on . Endocrine Today has compiled a list of recent FDA news stories relating to endocrine practice. Drugs under ...
As the only pituitary-directed therapy, Signifor represents a novel therapeutic approach by addressing the underlying mechanism of Cushing's disease[1] In the Phase III trial, most patients ...
Zacks Investment Research on MSN
Roche's breast cancer drug cuts risk of death by 30% in phase III
Roche RHHBY announced positive new data from a pre-specified interim analysis of its late-stage breast cancer study on ...
Heart failure and type 2 diabetes are exquisitely intertwined. Their shared pathophysiology can accelerate debilitating outcomes for patients that clinicians struggle to prevent and treat. People with ...
Researchers have discovered an unexpected relationship between levels of the amino acid leucine (found in beef, chicken, pork and fish and other foods) and the development of tamoxifen resistance in ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the endocrinology drugs market and it is poised to grow by USD 24.78 billion during 2020-2024, progressing at a CAGR of almost 7% during the ...
CARMEL, Ind.--(BUSINESS WIRE)--MBX Biosciences, a drug discovery company focused in rare endocrine diseases, today announced the closing of a $34.6 million Series A financing. The financing was led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback